These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 23299303)

  • 61. [Evaluation of the event-related potential (ERP-P300) in patients with hepatic cirrhosis without encephalopathy].
    Teodoro V; Bragagnolo M; Lucchesi L; Kondo M; Tufik S
    Arq Gastroenterol; 2008; 45(1):82-6. PubMed ID: 18425234
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Simple tools for complex syndromes: a three-level difficulty test for hepatic encephalopathy.
    Montagnese S; Schiff S; Turco M; Bonato CA; Ridola L; Gatta A; Nousbaum JB; Riggio O; Merkel C; Amodio P
    Dig Liver Dis; 2012 Nov; 44(11):957-60. PubMed ID: 22819289
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Cognition-tracking-based strategies for diagnosis and treatment of minimal hepatic encephalopathy.
    Han W; Zhang H; Han Y; Duan Z
    Metab Brain Dis; 2020 Aug; 35(6):869-881. PubMed ID: 32495311
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Inhibitory control test is a simple method to diagnose minimal hepatic encephalopathy and predict development of overt hepatic encephalopathy.
    Bajaj JS; Saeian K; Verber MD; Hischke D; Hoffmann RG; Franco J; Varma RR; Rao SM
    Am J Gastroenterol; 2007 Apr; 102(4):754-60. PubMed ID: 17222319
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Bispectral index monitoring for diagnosis and assessment of severity of hepatic encephalopathy in cirrhotic patients.
    Jindal A; Sharma BC; Sachdeva S; Chawla R; Srivastava S; Maharshi S
    Dig Liver Dis; 2015 Sep; 47(9):769-74. PubMed ID: 26022229
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Assessment and usefulness of clinical scales for semiquantification of overt hepatic encephalopathy.
    Sakamoto M; Perry W; Hilsabeck RC; Barakat F; Hassanein T
    Clin Liver Dis; 2012 Feb; 16(1):27-42. PubMed ID: 22321463
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Minimal hepatic encephalopathy.
    Dhiman RK; Chawla YK
    Indian J Gastroenterol; 2009; 28(1):5-16. PubMed ID: 19529896
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Management of covert hepatic encephalopathy.
    Mullen KD; Prakash RK
    Clin Liver Dis; 2012 Feb; 16(1):91-3. PubMed ID: 22321467
    [TBL] [Abstract][Full Text] [Related]  

  • 69. The animal naming test: An easy tool for the assessment of hepatic encephalopathy.
    Campagna F; Montagnese S; Ridola L; Senzolo M; Schiff S; De Rui M; Pasquale C; Nardelli S; Pentassuglio I; Merkel C; Angeli P; Riggio O; Amodio P
    Hepatology; 2017 Jul; 66(1):198-208. PubMed ID: 28271528
    [TBL] [Abstract][Full Text] [Related]  

  • 70. [Concentration problems, delayed reaction. "Diagnosis at a glance" points to hepatic encephalopathy].
    MMW Fortschr Med; 2003 Jun; 145(25):55. PubMed ID: 12891858
    [No Abstract]   [Full Text] [Related]  

  • 71. Minimal hepatic encephalopathy in patients with liver cirrhosis: magnetic resonance spectroscopic brain findings versus neuropsychological changes.
    Hassan EA; Abd El-Rehim AS; Seifeldein GS; Shehata GA
    Arab J Gastroenterol; 2014; 15(3-4):108-13. PubMed ID: 25459346
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Preliminary report of the Hepatic Encephalopathy Assessment Driving Simulator (HEADS) score.
    Baskin-Bey ES; Stewart CA; Mitchell MM; Bida JP; Rosenthal TJ; Nyberg SL
    Ethn Dis; 2008; 18(3):357-64. PubMed ID: 18785452
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Factors That Affect Results of Psychometric Tests to Identify Patients With Minimal Hepatic Encephalopathy.
    Pérez-Matos MC; Jiang ZG; Tapper EB
    Clin Gastroenterol Hepatol; 2018 Nov; 16(11):1836-1838. PubMed ID: 29551739
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Neuropsychological assessment of hepatic encephalopathy: ISHEN practice guidelines.
    Randolph C; Hilsabeck R; Kato A; Kharbanda P; Li YY; Mapelli D; Ravdin LD; Romero-Gomez M; Stracciari A; Weissenborn K;
    Liver Int; 2009 May; 29(5):629-35. PubMed ID: 19302444
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Critical flicker frequency as a marker of hepatic encephalopathy in patients before and after transjugular intrahepatic portosystemic shunt.
    Biecker E; Hausdörfer I; Grünhage F; Strunk H; Sauerbruch T
    Digestion; 2011; 83(1-2):24-31. PubMed ID: 20847560
    [TBL] [Abstract][Full Text] [Related]  

  • 76. The demise of the pencil? New computer-assisted tests for minimal hepatic encephalopathy.
    Iduru S; Mullen KD
    Gastroenterology; 2008 Nov; 135(5):1455-6. PubMed ID: 18848832
    [No Abstract]   [Full Text] [Related]  

  • 77. Hepatic encephalopathy and fitness to drive.
    Kircheis G; Knoche A; Hilger N; Manhart F; Schnitzler A; Schulze H; Häussinger D
    Gastroenterology; 2009 Nov; 137(5):1706-15.e1-9. PubMed ID: 19686744
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Mental status impairment in patients with West Haven grade zero hepatic encephalopathy: the role of HCV infection.
    Citro V; Milan G; Tripodi FS; Gennari A; Sorrentino P; Gallotta G; Postiglione A; Tarantino G
    J Gastroenterol; 2007 Jan; 42(1):79-82. PubMed ID: 17322997
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Prognostic Implications of Minimal/Covert Hepatic Encephalopathy: Large-scale Validation Cohort Studies.
    Flud CR; Duarte-Rojo A
    J Clin Exp Hepatol; 2019; 9(1):112-116. PubMed ID: 30765944
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Confounders in the detection of minimal hepatic encephalopathy: a neuropsychological and quantified EEG study.
    Campagna F; Montagnese S; Schiff S; Ruzzoli M; Biancardi A; Iannizzi P; Pujatti PL; Angeli P; Gatta A; Merkel C; Leandro G; Mapelli D; Amodio P
    Liver Int; 2015 May; 35(5):1524-32. PubMed ID: 25040245
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.